Back to School: How biopharma can reboot drug development. Access exclusive analysis here

New NIAID grants for biotech HIV programs

New NIAID grants for biotech HIV programs

The National Institute of Allergy and Infectious Diseases launched a new initiative, the Strategic Program for Innovative Research on AIDS Treatment (SPIRAT), to accelerate the development of therapies for HIV. First-year grants totalling $6.2 million

Read the full 427 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE